Among the 128 MPNs, approximately 43% (22/51) of PMF patients, 16.7% (7/41) of ET patients, and 19.4% (7/36) of PV patients developed CD13/CD16 phenotypic abnormalities (Fig. 4A). Here, ANPEP is linked to essential thrombocythemia.